Active Complement Factor B (CFB)
CF-B; BF; BFD; CFAB; GBG; H2-Bf; PBF2; B-Factor; Properdin; Properdin factor B; C3/C5 convertase; Glycine-rich beta glycoprotein
- Product No.APC011Si02
- Organism SpeciesRhesus monkey (Simian) Same name, Different species.
- Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- Traits Freeze-dried powder
- Purity> 80%
- Isoelectric Point7.5
- ApplicationsCell culture; Activity Assays.
- DownloadInstruction Manual
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$
US$
US$
US$
US$
For more details, please contact local distributors!
ACTIVITY TEST

Complement factor B (CFB), a 95-kDa protein, is a crucial catalytic element of the alternative pathway (AP) of complement. Upon cleavage by Complement Factor D (CFD), CFB splits into fragments Ba (inactive) and Bb, the latter forming the active C3 convertase (C3bBb). This enzyme amplifies complement activation by cleaving C3 into C3a/C3b, driving inflammation, opsonization, and membrane attack complex formation. CFB deficiency disrupts immune defense, linking it to infections and autoimmune disorders like atypical hemolytic uremic syndrome (aHUS).Thus a functional ELISA assay was conducted to detect the interaction of recombinant simina CFB and recombinant mouse CFD. Briefly, CFB was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to CFD-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CFB pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant simina CFB and recombinant mouse CFD was shown in Figure 1, the EC50 for this effect is 0.015 ug/mL.
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
-
BCA Protein Quantification Kit
-
Molecular Mass Marker for Protein
-
Monoclonal Antibody Customized Service
-
Polyclonal Antibody Customized Service
-
Protein Activity Test Experiment Service
-
Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
-
Buffer
-
Lentivirus Packaging Experiment Service
-
Adenovirus Packaging Experiment Service
-
Real Time PCR Experimental Service
-
Spike RBD Protein (S-RBD)
-
Protein G
-
Protein A
Magazine | Citations |
BMC Nephrology | Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis BioMed: 14712369 |
J. Proteome Res. | Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC–MS/MS ACS: pr300330z |
Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series PubMed: 25443527 |
Journal of Neuroimmunology | Acute and prolonged complement activation in the central nervous system during herpes simplex encephalitis Pubmed:27235358 |
Biochemical and Biophysical Research Communications | Adipose tissue complement factor B promotes adipocyte maturation. pubmed:29137982 |
Journal of proteome research | Serum exosomes from newborn piglets restrict porcine epidemic diarrhea virus infection |
journal of human genetics | Identification of susceptibility locus shared by IgA nephropathy and inflammatory bowel disease in a Chinese Han population Pubmed: 31857673 |
Nephrol Dial Transplant | Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis 33367879 |
JOURNAL OF GENERAL VIROLOGY | Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse 33410734 |
J Proteome Res | Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role 34766501 |
J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children Pubmed:35329889 |
Catalog No. | Related products for research use of Rhesus monkey (Simian) Organism species | Applications (RESEARCH USE ONLY!) |
RPC011Si01 | Recombinant Complement Factor B (CFB) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC011Si02 | Recombinant Complement Factor B (CFB) | Positive Control; Immunogen; SDS-PAGE; WB. |
APC011Si02 | Active Complement Factor B (CFB) | Cell culture; Activity Assays. |
PAC011Si01 | Polyclonal Antibody to Complement Factor B (CFB) | WB |
SEC011Si | ELISA Kit for Complement Factor B (CFB) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC011Si | Multiplex Assay Kit for Complement Factor B (CFB) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |